Finnish biotechnology start-up Solu has secured €1m ($1.2m) in seed funding from Lifeline Ventures and Wave Ventures to fight antibiotic resistance through building the world’s largest DNA library of pathogens. Studies show antibiotic resistance led to more than one million deaths in 2019, and caused almost five million people to die from bacterial infections resistant to antibiotics. Solu’s product can make understanding, detecting, and preventing the spread of antibiotic resistance more accessible and enable real-time monitoring for the detection of dangerous mutations. Solu aims to build the first pathogen DNA library that collects all pathogen data in real-time and can model their evolution and identify new health-threatening pathogens more effectively.
Helsinki’s Solu Secures €1 Million to Combat Global Antibiotic Resistance with Pathogen Data Analysis
Date:
Updated: [falahcoin_post_modified_date]
More like thisRelated
Revolutionary Small Business Exchange Network Connects Sellers and Buyers
Revolutionary SBEN connects small business sellers and buyers, transforming the way businesses are bought and sold in the U.S.
District 1 Commissioner Race Results Delayed by Recounts & Ballot Reviews, US
District 1 Commissioner Race in Orange County faces delays with recounts and ballot reviews. Find out who will come out on top in this close election.
Fed Minutes Hint at Potential Rate Cut in September amid Economic Uncertainty, US
Federal Reserve minutes suggest potential rate cut in September amid economic uncertainty. Find out more about the upcoming policy decisions.
Baltimore Orioles Host First-Ever ‘Faith Night’ with Players Sharing Testimonies, US
Experience the powerful testimonies of Baltimore Orioles players on their first-ever 'Faith Night.' Hear how their faith impacts their lives on and off the field.
